# Francis P. Worden

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/francis-p-worden/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,552 |
| Field | Head and Neck Cancer Studies |
| h-index | 64 |
| i10-index | 204 |
| Last Known Institution | University of Michigan |
| OpenAlex ID | https://openalex.org/A5022036818 |
| ORCID iD | https://orcid.org/0000-0002-6632-4951 |
| Works | 549 |

## Researcher papers

- [Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck](https://scholariq.org/papers/nivolumab-for-recurrent-squamous-cell-carcinoma-of-the-head-and-neck/)
- [Integrative clinical genomics of metastatic cancer](https://scholariq.org/papers/integrative-clinical-genomics-of-metastatic-cancer/)
- [Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression](https://scholariq.org/papers/nivolumab-vs-investigator-s-choice-in-recurrent-or-metastatic-squamous-cell/)
- [Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers](https://scholariq.org/papers/efficacy-of-selpercatinib-in-i-ret-i-altered-thyroid-cancers/)
- [Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study](https://scholariq.org/papers/pembrolizumab-for-platinum-and-cetuximab-refractory-head-and-neck-cancer-results/)
- [Management of patients with adrenal cancer: recommendations of an international consensus conference](https://scholariq.org/papers/management-of-patients-with-adrenal-cancer-recommendations-of-an-international/)
- [Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial](https://scholariq.org/papers/pembrolizumab-plus-cetuximab-in-patients-with-recurrent-or-metastatic-head-and/)

## Researcher topics

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Thyroid Cancer Diagnosis and Treatment](https://scholariq.org/topics/thyroid-cancer-diagnosis-and-treatment-2/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Salivary Gland Tumors Diagnosis and Treatment](https://scholariq.org/topics/salivary-gland-tumors-diagnosis-and-treatment/)

## Researcher university

- [University of Michigan](https://scholariq.org/institutions/university-of-michigan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.